Biomolecular and Proteomics Shared Resource
生物分子和蛋白质组学共享资源
基本信息
- 批准号:8733538
- 负责人:
- 金额:$ 28.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Applications GrantsBioinformaticsBiological MarkersBiopsy SpecimenCancer CenterCancer Center Support GrantCapitalCapital FinancingCategoriesCommunitiesDataDoctor of PhilosophyEducational workshopEquipmentFacultyFees and ChargesFloorFundingGelHistologyHousingHumanHuman ResourcesImageIndividualLaboratoriesLearningLinkLipidsLiquid substanceMalignant NeoplasmsMass Spectrum AnalysisMeasurementMedical ResearchMicroscopeMissionNCI Center for Cancer ResearchPharmaceutical PreparationsPhysiologicalPostdoctoral FellowProcessProgram Research Project GrantsProteinsProteomicsProteomics Shared ResourceResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResolutionResource SharingResourcesRobotServicesSite VisitSoftware ToolsStructureTechniquesTechnologyTimeTissuesTrainingTraining ProgramsUnited States National Institutes of HealthUniversitiesVisitbasecostcost effectivedesigndigitalfluorescence imaginggraduate studentimprovedinstrumentinstrumentationlaboratory facilitylecturesmass spectrometermembernovelprogramsprotein profilingresearch studysmall moleculesquare foottoolwhole animal imaging
项目摘要
The mission of the Biomolecular & Proteomics Shared Resource (BPSR) is to provide cost-effective,
state-of-the-art instrumentation and analytical expertise to investigators in the Vanderbilt-lngram Cancer
Center (VICC). The shared resource consists of three specialized laboratories dedicated to analysis of small
molecules (i.e., drugs, drug metabolites and endogenous metabolites) In tissues and physiologic fluids; a
comprehensive analytical proteomics facility for identification, characterization and quantitation of proteins;
and a mass spectrometry imaging and histology-directed protein profiling facility. At the time of the last
competitive renewal, these activities were separated into three independent shared resources, each
receiving an "Outstanding" rating. Combining them into a single administrative structure has improved
efficiency and service, while cutting costs. The facility currently houses 17 mass spectrometers. Other
specialized capital equipment for imaging and proteomic studies are also available, such as high resolution
matrix spotters, a cryomacrotome for whole animal imaging studies, a high resolution digital microscope for
documenting histology data, a 2D gel fluorescence imaging and 2D gel processing robot. A bioinformatics
support staff develops new software tools to support the shared resource and maintains the computing
infrastructure. Justifications for including this shared resource in the CCSG proposal include (1) the
extensive use of mass spectrometry services by the VICC research community, (2) the unique and
comprehensive array of services offered to investigators, and (3) the cost-effective delivery of these services
by a highly skilled professional staff. In FY 2008, 95 VICC/CCSG research groups used these services. The
shared resource provides 16 categories of analytical services covering a wide range of analytical
measurements from drug quantitation for PK/PD studies; identification, characterization and quantitation of
cancer biomarkers; and imaging and profiling of proteins, lipids and drugs in human biopsy samples. The
shared resource is supported by the CCSG, by research grants to individual investigators, and by significant
institutional support from Vanderbilt.
生物分子和蛋白质组学共享资源(BPSR)的使命是提供具有成本效益的,
范德比尔特癌癌症研究人员的最先进的仪器和分析专业知识
中心(VICC)。共享资源由三个专门用于分析小型的专业实验室组成
组织和生理液中的分子(即药物,药物代谢产物和内源代谢产物);一个
用于鉴定,表征和定量蛋白质的综合分析蛋白质组学设施;
以及质谱成像和组织学指导的蛋白质分析设施。最后一个
竞争性更新,将这些活动分为三个独立共享资源,每个资源
获得“未偿”评级。将它们组合成单个行政结构已改善
效率和服务,同时削减成本。该设施目前容纳17个质谱仪。其他
还提供用于成像和蛋白质组学研究的专门资本设备,例如高分辨率
矩阵示例,一种用于全动物成像研究的冷冻剖面,是一种高分辨率数字显微镜
记录组织学数据,2D凝胶荧光成像和2D凝胶处理机器人。生物信息学
支持人员开发了新的软件工具来支持共享资源并维护计算
基础设施。 CCSG建议中包含此共享资源的理由包括(1)
VICC研究社区广泛使用质谱服务,(2)独特和
向调查人员提供的全面服务,以及(3)这些服务的具有成本效益的交付
由高技能的专业员工。在2008财年,有95个VICC/CCSG研究小组使用了这些服务。这
共享资源提供16种涵盖广泛分析的分析服务
来自PK/PD研究的药物定量测量;识别,表征和定量
癌症生物标志物;以及人类活检样品中蛋白质,脂质和药物的成像和分析。这
共享资源得到了CCSG的支持,研究赠款给个人调查员以及大量
范德比尔特的机构支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L HACHEY其他文献
DAVID L HACHEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L HACHEY', 18)}}的其他基金
A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions
准确区分黑色素瘤和良性病变的分子诊断方法
- 批准号:
9926849 - 财政年份:2018
- 资助金额:
$ 28.33万 - 项目类别:
A Molecular Diagnostic Assay for Accurately Differentiating Melanoma from Benign Lesions
准确区分黑色素瘤和良性病变的分子诊断方法
- 批准号:
9905050 - 财政年份:2018
- 资助金额:
$ 28.33万 - 项目类别:
LTQ Orbitrap XL ETD Hybrid FT High Resolution Mass Spectrometer
LTQ Orbitrap XL ETD 混合 FT 高分辨率质谱仪
- 批准号:
7793941 - 财政年份:2010
- 资助金额:
$ 28.33万 - 项目类别:
相似国自然基金
整合多层次组学数据发现复杂疾病标记物的生物信息学方法研究
- 批准号:61973190
- 批准年份:2019
- 资助金额:60 万元
- 项目类别:面上项目
基于全基因组测序建立病毒拷贝数和整合位点的生物信息学方法及数据分析
- 批准号:81770205
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
缺血性脑卒中康复期特异的复合生物标记模块筛选方法研究
- 批准号:61702496
- 批准年份:2017
- 资助金额:29.0 万元
- 项目类别:青年科学基金项目
基于定量蛋白质组学的鸡蛋储藏期间劣化分子机制研究
- 批准号:31772043
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
基于microRNA技术的精神分裂症相关生物标记物的遗传流行病学研究
- 批准号:81673253
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Novel circulating biomarker digital scores for assessing treatment response in liver cancer
用于评估肝癌治疗反应的新型循环生物标志物数字评分
- 批准号:
10651050 - 财政年份:2023
- 资助金额:
$ 28.33万 - 项目类别:
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
用于早期非小细胞肺癌检测和预后的微生物和宿主生物标志物开发
- 批准号:
10701254 - 财政年份:2023
- 资助金额:
$ 28.33万 - 项目类别:
Mentoring the next generation of substance use, HIV, and epigenetic researchers in sexual and gender minority health
指导下一代性和性别少数健康领域的药物滥用、艾滋病毒和表观遗传学研究人员
- 批准号:
10699933 - 财政年份:2023
- 资助金额:
$ 28.33万 - 项目类别:
Novel circulating biomarker digital scores for assessing treatment response in liver cancer
用于评估肝癌治疗反应的新型循环生物标志物数字评分
- 批准号:
10370966 - 财政年份:2022
- 资助金额:
$ 28.33万 - 项目类别:
Role of FAT1 somatic mutations in aggressiveness of head and neck cancer
FAT1体细胞突变在头颈癌侵袭性中的作用
- 批准号:
10510325 - 财政年份:2022
- 资助金额:
$ 28.33万 - 项目类别: